Identification of novel biomarkers and therapeutic targets for steatohepatitis and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD): an in silico analysis

被引：0
|
作者：
Maya-Miles, Douglas [1 ,2 ]
Gallego-Duran, Rocio [1 ,2 ]
Munoz Hernandez, Rocio [1 ,2 ]
Rojas, Angela [1 ,2 ]
Gil-Gomez, Antonio [1 ,2 ]
Montero-Vallejo, Rocio [1 ,2 ]
Gato, Sheila [1 ,2 ]
Giraldez-Jimenez, Maria [1 ,2 ]
Ampuero, Javier [1 ,2 ]
Romero Gomez, Manuel [1 ,2 ]
机构：
[1] Univ Seville, Hosp Univ Virgen Rocio, Seliver Grp, Inst Biomed Sevilla IBiS,CSIC, Seville, Spain
[2] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain
来源：
JOURNAL OF HEPATOLOGY | 2020年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
SAT014
引用
收藏
页码：S660 / S660
页数：1
相关论文
共 50 条
  • [21] FUNCTIONAL PATHWAY ANALYSIS OF GENE EXPRESSION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NON-ALCOHOLIC STEATOHEPATITIS (NASH)
    Stepanova, M.
    Manyam, G.
    Hossain, N.
    Chandhoke, V.
    Baranova, A.
    Goodman, Z.
    Younossi, Z.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S313 - S313
  • [22] Predictors of non-alcoholic steatohepatitis and fibrosis in non-alcoholic fatty liver disease.
    Pong, JP
    Elariny, H
    Younoszai, A
    HEPATOLOGY, 2002, 36 (04) : 407A - 407A
  • [23] Comment on: Novel therapeutic targets for non-alcoholic fatty liver disease
    Athyros, Vasilios G.
    Katsiki, Niki
    Karagiannis, Asterios
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2013, 17 (07) : 861 - 862
  • [24] Clinical predictors of advanced fibrosis in patient with non-alcoholic fatty liver disease (NAFLD)
    Siua, W.
    Andiganib, M.
    Frasera, A.
    Vijayana, B.
    Mclemana, L.
    Englisha, S.
    Mukhopadhyaa, A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 187 - 187
  • [25] MITOCHONDRIAL DNA CONTENT IS ASSOCIATED WITH ADVANCED FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Mehta, Rohini
    Sproelich, Maya
    Bondurant, Sarah
    Estep, James M.
    Abdul-Al, Hala
    Paik, James
    Felix, Sean C.
    Younossi, Zobair M.
    GASTROENTEROLOGY, 2018, 154 (06) : S1096 - S1096
  • [26] Relationship of sarcopenia with steatohepatitis and advanced liver fibrosis in non-alcoholic fatty liver disease: a meta-analysis
    Rui Yu
    Qiangwei Shi
    Lei Liu
    Lidong Chen
    BMC Gastroenterology, 18
  • [27] Relationship of sarcopenia with steatohepatitis and advanced liver fibrosis in non-alcoholic fatty liver disease: a meta-analysis
    Yu, Rui
    Shi, Qiangwei
    Liu, Lei
    Chen, Lidong
    BMC GASTROENTEROLOGY, 2018, 18
  • [28] Immunology of gut microbiome and liver in non-alcoholic fatty liver disease (NAFLD): mechanisms, bacteria, and novel therapeutic targets
    Stanislav Konstantinovich Gruzdev
    Irina Viktorovna Podoprigora
    Oksana Anatolievna Gizinger
    Archives of Microbiology, 2024, 206
  • [29] Non-alcoholic Fatty Liver Disease (NAFLD) and non-alcoholic Steatohepatitis (NASH): Pathophysiology and Nutritional Aspects
    Schattenberg, Joern M.
    ERNAHRUNGS UMSCHAU, 2015, 62 (02): : M92 - M100
  • [30] Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course
    Cortez-Pinto, H
    Camilo, ME
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2004, 18 (06) : 1089 - 1104
12345